| abstract |
REFERRING TO A COMPOUND OF FORMULA I WHERE X IS O, S, AMONG OTHERS; n IS 1-2; R1 IS H, CN, CHO, AMONG OTHERS; R2 IS C1-C6 ALKYL, C3-C7 CYCLOALKYL, ARYL, AMONG OTHERS; R3 IS HALOGEN, CN, C1-C6 ALKYL, AMONG OTHERS; R4 AND R5 ARE EACH H, C1-C6 ALKYL, C2-C6 ALKYL, AMONG OTHERS. ALSO REFERRED TO A COMPOSITION N, N-DIMETHYL-3- (PHENYLSULFONIL) -6,7,8,9-TETRAHYDRO-3H-BENZO [e] INDOL-8-AMINE, 3 - [(2,6-DICHLOROIMIDAZOLE [2 , 1-b] [1,3] THIAZO-5-LYL) SULFONIL] -N, N-DIMETHYL-6,7,8,9-TETRAHYDRO-3H-BENZO [e] INDOL-8-AMINE, AMONG OTHERS. SAID COMPOUND IS USEFUL IN THE TREATMENT OF CNS DISORDER RELATED TO OR AFFECTED BY THE 5-HT6 RECEPTOR |